KLA Corp. vs 10X Genomics Inc — how do they compare? KLA Corp. trades at $218 (market cap $271.18B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: KLA Corp. is far larger — about 49.5× 10X Genomics Inc's market cap, and KLA Corp. pays a 0.44% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| KLAC | TXG | |
|---|---|---|
Market Cap | $271.18B | $5.48B |
Sector | Technology | Health |
52-Week High | $301.71 | $45.80 |
52-Week Low | $84.39 | $11.34 |
Enterprise Value | $272.37B | $5.02B |
Dividend Yield | 0.44% | — |
Trailing returns across standard periods
Latest headlines on both assets
KLA designs and manufactures yield-management and process-monitoring diagnostic and control systems for the semiconductor manufacturing industry. The systems are used to analyze the manufacturing process at various steps in a semiconductor's development. The firm's laser-scanning products are used for wafer qualification, process monitoring, and equipment monitoring. KLA also provides inspection tools and systems for optical metrology and e-beam metrology.
Read more on KLAC →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →